Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification
GeoVax Advances GEO-MVA to Strengthen U.S. and Global Readiness. ATLANTA, GA - February 19, 2025 (NEWMEDIAWIRE) - The confirmation of a fourth case of Clade 1 Mpox in New York und ...
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health
GeoVax's Vaccine Development Programs Align with Anticipated HHS Focus on Vaccine Safety, Diversification and Domestic ...
News Medical11 天
Engineering safe and effective vaccinia virus vectors for next-generation vaccines
Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against ...
EurekAlert!12 天
Strategies for the modification of vaccinia virus towards a better vaccine vector
Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been ...
GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate ...
President Trump’s Stargate Initiative, supported by up to $500 billion in private-sector investment, represents a bold step forward in embracing transformative technologies. GeoVax proudly aligns with ...